EndoSonics of Rancho Cordova, CA, announced this month an agreement with Jomed of Helsingborg, Sweden, to develop an intravascular ultrasound-guided stent delivery system together. The new system will integrate EndoSonics’ electronic imaging
EndoSonics of Rancho Cordova, CA, announced this month an agreement with Jomed of Helsingborg, Sweden, to develop an intravascular ultrasound-guided stent delivery system together. The new system will integrate EndoSonics electronic imaging catheter with Jomeds stent and balloon devices. The two firms hope their combined product will decrease post-angioplasty complications and streamline interventional procedures. Jomed anticipates marketing the device in early 1999, pending CE Mark approval.
In other EndoSonics news, the company announced that it has agreed to a five-year hiatus in its intellectual property claim litigation with Intravascular Research of the U.K. The temporary truce includes closing a Delaware lawsuit between the companies involving patent infringement disputes.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
MRI-Based AI Model Shows Promise in Predicting Lymph Node Metastasis with Breast Cancer
April 15th 2024For the prediction of axillary lymph node metastasis in patients with breast cancer, an MRI-based, 4D convolutional neural network model demonstrated an AUC of 87 percent and sensitivity of 89 percent, according to new research.